We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASPS icon
2476
Altisource Portfolio Solutions
ASPS
$58.4M
$91.6K ﹤0.01%
+2,488
New +$120K
SMHI icon
2477
SEACOR Marine Holdings
SMHI
$209M
$91.2K ﹤0.01%
+11,982
New +$114K
UPLD icon
2478
Upland Software
UPLD
$13.3M
$89.9K ﹤0.01%
+2,090
New +$145K
NEX
2479
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$89K ﹤0.01%
11,200
-118,500
-91% -$1.06M
VRCA icon
2480
Verrica Pharmaceuticals
VRCA
$89M
$87.2K ﹤0.01%
+1,341
New +$81.1K
LCTX icon
2481
Lineage Cell Therapeutics
LCTX
$264M
$83.5K ﹤0.01%
55,646
+18,528
+50% +$25.9K
ICVX
2482
DELISTED
Icosavax, Inc. Common Stock
ICVX
$83.4K ﹤0.01%
+14,387
New +$124K
FXB icon
2483
PUT
Invesco CurrencyShares British Pound Sterling Trust
FXB
$77.1M
$83.1K ﹤0.01%
700
-3,400
-83% -$398K
SYRS
2484
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$81.6K ﹤0.01%
+30,551
New +$118K
NEON icon
2485
Neonode
NEON
$12.6M
$80.1K ﹤0.01%
+10,527
New +$86.8K
ALXO icon
2486
ALX Oncology
ALXO
$262M
$79.5K ﹤0.01%
+17,583
New +$133K
NIU
2487
Niu Technologies
NIU
$200M
$78.2K ﹤0.01%
+18,900
New +$87.7K
TUYA
2488
Tuya Inc
TUYA
$1.04B
$77.8K ﹤0.01%
41,162
RTB
2489
RTB Digital
RTB
$230M
$77.6K ﹤0.01%
541
SCOR icon
2490
Comscore
SCOR
$113M
$72.8K ﹤0.01%
2,959
ICD
2491
DELISTED
Independence Contract Drilling, Inc.
ICD
$72.6K ﹤0.01%
22,268
+5,200
+30% +$20K
BLDP
2492
Ballard Power Systems
BLDP
$754M
$72.4K ﹤0.01%
+13,000
New +$75K
ADV icon
2493
Advantage Solutions
ADV
$575M
$68.8K ﹤0.01%
1,741
-1,899
-52% -$107K
SCHW
2494
CALL
Charles Schwab
SCHW
$182B
$68.1K ﹤0.01%
1,300
-39,500
-97% -$2.89M
PPTA
2495
Perpetua Resources
PPTA
$2.16B
$67.7K ﹤0.01%
+15,220
New +$52.7K
PETWW
2496
CALL
DELISTED
Wag! Group Co Warrant
PETWW
$65.8K ﹤0.01%
29,388
SVRA icon
2497
Savara
SVRA
$1.08B
$65K ﹤0.01%
+33,333
New +$75.1K
YI
2498
111 Inc
YI
$31.3M
$62.4K ﹤0.01%
2,354
-14,180
-86% -$416K
KZR
2499
DELISTED
Kezar Life Sciences
KZR
$61.6K ﹤0.01%
1,968
+693
+54% +$40.1K
XLK icon
2500
PUT
State Street Technology Select Sector SPDR ETF
XLK
$109B
$60.4K ﹤0.01%
800
-15,600
-95% -$1.07M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.